<SEC-DOCUMENT>0001193125-21-107770-index.html : 20210406
<SEC-HEADER>0001193125-21-107770.hdr.sgml : 20210406
<ACCEPTANCE-DATETIME>20210406172559
ACCESSION NUMBER:		0001193125-21-107770
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20210406
DATE AS OF CHANGE:		20210406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			4D Molecular Therapeutics Inc.
		CENTRAL INDEX KEY:			0001650648
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473506994
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39782
		FILM NUMBER:		21810025

	BUSINESS ADDRESS:	
		STREET 1:		5858 HORTON STREET #455
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5105052680

	MAIL ADDRESS:	
		STREET 1:		5858 HORTON STREET #455
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	4D Molecular Therapeutics Inc
		DATE OF NAME CHANGE:	20150811
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d164238ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: d164238ddefa14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g164238g48q70.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: g164238g48q70.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g164238na3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g164238na3.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g164238na4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g164238na4.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g164238na5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g164238na5.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g164238newcontrl.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g164238newcontrl.jpg

</DOCUMENT>
</SEC-DOCUMENT>